Company: RCUS
Filing Date: 2025-04-22
Form Type: DEF 14A
Source: 0001724521-25-000052
Chunk: 62

Company: Arcus Biosciences, Inc.
Filing Date: 2025-04-22
Form: DEF 14A
Chunk 62
---
 402(v)(2)(vi) of Regulation S-K to link compensation actually paid to our performance. The most important performance measures that we use to link executive compensation actually paid to our named executive officers, for the most recently completed fiscal year, to company performance are as follows:

• Expansion of our co-development programs with our strategic partners;

• Initiation of new registrational trials;

• Demonstrating proof of concept for investigational products;

• Nomination of new development candidates; and

• Efficient utilization of our resources in the advancement and execution of our clinical programs and pipeline.

<div align='center'>35.</div>

The graphs below show the relationship between (i) the compensation actually paid to both our Chief Executive Officer and the Other NEOs for the years set forth in the Pay versus Performance Table and (ii) the net income/loss and total shareholder return for the corresponding years:

All information provided above under the “Pay Versus Performance” heading will not be deemed to be incorporated by reference into any of our filings under the Securities Act of 1933, as amended, or the Exchange Act whether made before or after the date hereof and irrespective of any general incorporation language in any such filing, except to the extent we specifically incorporate such information by reference.

Compensation Committee Interlocks and Insider Participation

As noted above, the Compensation Committee currently consists of Dr. Kaneko, Dr. Lacey and Ms. Lambert. None of the members of our Compensation Committee has at any time during the past three years been one of our officers or employees. None of our executive officers currently serve or in the prior three years has served as a member of the board of directors or compensation committee of any entity that has one or more executive officers serving on the Board or Compensation Committee.

<div align='center'>36.</div>

### COMPENSATION OF DIRECTORS

#### Cash Compensation
Pursuant to our Compensation Program for Non-Employee Directors, we pay each of our non-employee directors annual cash retainers, paid quarterly in arrears, as follows:

|                                                                                             |     |   |     Prior to 
 June 6, 2024 |     |   | Subsequent to 
  June 6, 2024 |
|:--------------------------------------------------------------------------------------------|:----|:--|-------------:|:----|:--|--------------:|
| Retainer for each non-employee member of the Board:                                         |     | $ |       45,000 |     | $ |        45,000 |
| Additional